Indicated for the treatment of subclinical mastitis caused by
susceptible strains of Staphlycoccus aureus and Streptococcus agalactiae
in dry cows.

▪Provides synergistic antibiotic combination of penicillin and
novobiocin
▪Batericidal activity against major Staphlococcus and Streptococcus
mastitis pathogens
▪Ideal duration of activity during the involution phase of the dry cow
period, when the keatin plug has not formed and the cow is susceptible
to infections
▪Contents of one syringe are infused into each quarter at dry off
▪72-hour milk withhold following calving
▪30-day preslaughter withdrawal required following administration